Japan OK’s Pfizer Vaccine for XBB.1.5 Omicron Variant
15:05 JST, September 2, 2023
The Health, Labor and Welfare Ministry gave special approval for the manufacture and sale of Pfizer Inc.’s vaccine for XBB.1.5, a new omicron variant of the novel coronavirus, in Japan on Friday.
Those 6 months or older will be eligible to receive the U.S. pharmaceutical company’s vaccine. Inoculations will begin on Sept. 20 in preparation for the expected spread of coronavirus infections during the year-end and New Year’s holidays.
The shots will be administered for free during fiscal 2023.
"Society" POPULAR ARTICLE
-
Cherry tree falls on man on Sanneizaka steps leading to famous Kiyomizu Temple in Kyoto
-
Tokyo District Court Rules AI Cannot Be Issued Patents; Law Recognizes Only ‘Natural Persons’ as Inventors
-
Small Animal That Appears to be Mouse Found in Chojuku Bread Products; Some Brands on Same Production Line to be Recalled Voluntarily
-
Earthquake Hits Japan’s Ibaraki, Tochigi, Chiba Prefectures, No Risk of Tsunami
-
Man Repels Bear Attack in Hokkaido by Kicking its Face After Encountering 2 Bears While Sightseeing
JN ACCESS RANKING
- Weakening Yen Adds Complexity to BOJ’s Rate Hike Decisions; Rising Commodity Prices may Impact ‘Virtuous Cycle’ Efforts
- Japanese Seafood Exports to China Sink 57% in FY23; U.S. Becomes Largest Seafood Export Destination
- 70% of Japan Companies to Raise Pay Scales in FY 2024
- ASEAN Plus 3 Share Concerns About Excessive Exchange Rate Fluctuation; Seeking Stability in Exchange Rate
- Minutes Show Policymaker Wants BOJ to Consider Further Rate Hikes Further